Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Netflix
NFLX
5
Palantir
PLTR
JP Stock MarketDetailed Quotes
4598 Delta-Fly Pharma
- 436
- -6-1.36%
20min DelayTrading Apr 22 09:45 JST
4.24BMarket Cap-2.19P/E (Static)
443High435Low77.20KVolume440Open442Pre Close33.88MTurnover77652wk High0.99%Turnover Ratio9.73MShares40352wk Low-218.3EPS TTM3.39BFloat Cap5380Historical HighLossP/E (Static)7.78MShs Float403Historical Low-198.78EPS LYR1.81%Amplitude--Dividend TTM12.45P/B100Lot Size--Div YieldTTM
Delta-Fly Pharma News
The shareholding percentage of Delta F and Macquarie Bank has risen to 6.91%.
It has been revealed that Macquarie Bank's Shareholding in Delta-Fly Pharma <4598.T> has increased. According to a large Shareholding change report submitted by Macquarie Bank after the market close on the 18th of last week, the Shareholding rose from 5.33% at the last submission to 6.91%. The purpose of the Shareholding is for pure investment. The closing price on the 18th of last week was 456 yen, up 21 yen from the previous day. Provided by Wealth Advisor Inc.
Express News | [Change Report] Macquarie Silver in Australia reports an increase in Shareholding of Delta-Fly Pharma (4598.JP) to 6.91%.
Globee, ABEJA and others.
Logos HD has revised down its operating profit forecast for this term to 0.25 billion yen from 0.886 billion yen. Iore has established a capital and business alliance with ZUU. Groving has revised up its operating profit forecast for this term to 2.6 billion yen from 2.184 billion yen. J Frontier has revised up its operating profit forecast for this term to 0.21 billion yen from a range of -2.00 to 0 billion yen. The Agriculture Comprehensive Research Institute has revised up its operating profit forecast for this term to 0.2 billion yen from 0.11 billion yen for the fiscal year ending in August 2025 to 2027.
A strong trend with a dominant buy on dips, but upward movement may be heavy.
[Emerging Markets Individual Stock Global Strategy] The Emerging Markets are expected to perform strongly today. In the U.S. stock market yesterday, the Dow Inc closed down by $11.80 (-0.03%) at $41,989.96, showing a slight decline. Concerns ahead of the announcement of reciprocal tariffs by the Trump administration, along with the ISM manufacturing Index ETF and JOLT job openings falling below expectations, heightened fears of growth slowdown, which weighed on stock prices. On the other hand, the rise in the high-tech Sector supported recovery, and the Nasdaq returned to positive territory. Today's Emerging Markets.
The shareholding ratio of DeltaF and Macquarie Bank has decreased to 5.33%.
It has been revealed that Macquarie Bank's Shareholding in DeltaF<4598.T> has decreased. According to the large Shareholding change report submitted by Macquarie Bank after the market closed on the 28th of last week, the Shareholding percentage dropped from 6.79% during the last submission to 5.33%. The purpose of the Shareholding is pure investment. The closing price on the 28th of last week was 582 yen, up 22 yen from the previous day. Source: Wealth Advisor Inc.
Express News | [Change Report] Macquarie Silver in Australia reports a decrease in its Shareholding of Delta-Fly Pharma (4598.JP) to 5.33%.
Delta-Fly Pharma to Start Phase 2/3 Trial of DFP-17729 for Pancreatic Cancer
March 25 [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Mimaki Engineering <6638> 1471 yen (3/24) Engaged in industrial inkjet printers, cutting plotters, etc. Announced a Financial Estimates of 25.0 yen for the ordinary dividends at the end of the fiscal year ending March 2025, plus a special dividend of 10.0 yen. The year-end dividend will be 35.0 yen (including a special dividend of 10.0 yen). The previous estimate was only an ordinary dividend of 15.0 yen, and the year-end dividend for the previous term was 15.0 yen. The annual dividend will be 52.5 yen.
The market is stable, supported by the rise in U.S. stocks, but resistance may be strong at higher levels.
[Emerging Markets Individual Stock Strategy] Today's Emerging Markets are expected to show a solid performance. On the US Stock Market yesterday, October 24, the Dow Inc rose significantly by 597.97 points (+1.42%) to 42,583.32 dollars. Reports suggested that the Trump administration's 'reciprocal tariffs' would be focused, and the unexpected rise in the March Services PMI supported stock prices. The buybacks in the high-tech sector continued, expanding the gain into the latter part of the day. Today's Emerging Markets are likely to experience a favorable buying trend.
＜Today's individual materials＞ Nakabotech, Creos, Bright Path, Nitto Kohki, ETC (announcements on the 24th)
▽ Nakabotec <1787.T> has revised its standalone financial estimates for the fiscal year ending March 2025 upward, raising its year-end total dividends estimate from 200 yen to 275 yen (previous fiscal year's figure was 240 yen). ▽ Creos <8101.T> has increased its year-end total dividends estimate for the fiscal year ending March 2025 from 90 yen to 95 yen (previous fiscal year's figure was 83 yen). ▽ Bright Pass <4594.T> has revised its standalone profit estimates downward for the fiscal year ending March 2025. ▽ Nitto Kohki <6151.T> has lowered its consolidated financial estimates for the fiscal year ending March 2025, and has adjusted its year-end dividends estimate accordingly.
Mirai Works, Cell Seed and others.
The acquisition of shares in Sky 365, which is involved in MSP (operations, monitoring, maintenance) business and Software Development related to Beex Cloud. <4594> Brightpath has revised its Financial Estimates, projecting an operating loss of 1.114 billion yen for this term, compared to 0.925 billion yen previously. <4598> A clinical phase 2/3 comparative trial of DELTA-PDFP-17729 has begun. <4881> A large exercise of the 12th subscription rights of Fanpepp with price adjustment clauses will start on the 17th, with the number of shares to be delivered being 85.
Key points of interest for PTS on the 24th = Maruha Nichiro, Daiko, Apirits.
▽ Maruha Nichiro <1333.T>, announcement of new long-term vision and medium-term management plan ▽ Daiko <3160.T>, Earnings Reports and revision of Financial Estimates ▽ Apirits <4174.T>, consolidated subsidiary acquires stocks of JUTJOY (becoming a subsidiary) ▽ BeeX <4270.T>, acquires Sky 365 as a subsidiary ▽ DeltaF <4598.T>, starts clinical phase 2/3 comparative trial for DFP-17729 ▽ Mimaki Engineering <6638.T>, revision of Dividends forecast ▽ Ikegami Tsusho <6771.T>, performance and Dividends.
Individual stock information.
BTM <5247.T> rebounded significantly after eight days of decline. A 1-for-2 Stock Splits will be carried out with March 31 as the record date and April 1 as the effective date. Palma <3461.T> continued to rise significantly. It will change markets from the Tokyo Growth Market to the Tokyo Standard Market on the 7th. DeltaF <4598.T> rebounded. The Phase 1 portion (dose setting) of the clinical trial for 'DFP-10917' in combination with 'Venetoclax (VEN)' targeting patients with acute myeloid leukemia in the second-line treatment.
Strong, supported by rising US stocks and declining US long-term interest rates.
[Emerging Markets Individual Stock Global Strategy] Today's Emerging Markets are expected to have a steady performance. On the US stock market at the end of last week on February 28, the Dow Inc rose by 601.41 points (+1.39%) to 43,840.91 dollars, showing a significant rebound after three days. The Core PCE price index confirmed the expected trend of slowing inflation, strengthening the buying pressure due to rate cut expectations. On the other hand, the breakdown of the US and Ukraine summit discussions diminished hopes for a ceasefire, putting pressure on stock prices; however, as the end of the month approached, there was a strong tendency for buybacks, leading to an increase in market momentum towards the end.
Palma, BTM and other [Emerging Markets press release]
＜265A＞ Acquisition of a portion of the business from IP Partners, which is engaged in IT consulting, etc. ＜3133＞ Complete subsidiary acquisition of NEPAL HYDRO POWER HOLDINGS, which develops and operates renewable Energy projects overseas through a simple stock exchange ＜3461＞ Approval granted for the market change to the standard market on the Tokyo Stock Exchange ＜3542＞ Completion of the repurchase of VEGA's own shares ＜4450＞ PSOL from the fiscal year ending December 2025 to January 2027.
Delta-Fly Pharma, Inc.: Progress of Development Status of the Combination Study of DFP-10917 With Venetoclax
Delta-Fly Pharma: 3Q financial results presentation materials for the fiscal year ending 2025/3 20250214
Delta-Fly Pharma Sees Parent FY Loss Y1.83B
Delta-Fly Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2025 [Japanese GAAP] (unconsolidated)
Kirin HD, Matsukiyo Cocok, Dentsu Group, Rakuten Group (14th) (1379-5368)
The above Calendar is merely a schedule and is subject to change due to the company's circumstances.--------------------------------------- February 14 (Friday) <1379> Hokuto <1380> Akigawa Boku-en <1417> Mirait-Wan <142A> Jinjibu <1438> Gifu Landscaping <1443> Giken HD <1447> SAAF HD <145A> Elizbee<
Market Insights
Discussing
Gold price hits new high! Safe havens in a turbulent market?
🎙️Discussion 1. The spot gold price climbed to an all-time high, with numerous institutions raising their gold price forecasts, would you b
Riddick705
Apr 9 22:07
Dont Get Smoked!